Orchestra BioMed Holdings, Inc. (OBIO)

NASDAQ: OBIO · IEX Real-Time Price · USD

8.03

0.00 (0.00%)

At close: Jul 19, 2024, 4:00 PM

8.09

+0.06 (0.75%)

Pre-market: Jul 20, 2024, 9:29 AM EDT

Orchestra BioMed Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2.22	2.76	3.53	-0.78	5.7
Revenue Growth (YoY)	-42.16%	-21.88%	-	-	-
Cost of Revenue	0.18	0.19	0.21	0.2	0.15
Gross Profit	2.04	2.57	3.32	-0.98	5.56
Selling, General & Admin	21.74	20.26	14.03	7.93	10.83
Research & Development	34.68	33.82	21.95	12.89	13.48
Operating Expenses	56.42	54.08	35.98	20.82	24.31
Operating Income	-54.38	-51.51	-32.66	-21.8	-18.75
Interest Expense / Income	0.89	0	0	0.93	-0.33
Other Expense / Income	-3.63	-2.39	0.95	0.29	2.93
Pretax Income	-51.64	-49.12	-33.61	-23.01	-21.36
Net Income	-51.64	-49.12	-33.61	-23.01	-21.36
Shares Outstanding (Basic)	36	33	15	9	2
Shares Outstanding (Diluted)	36	33	15	9	2
Shares Change	29.43%	121.67%	69.97%	337.98%	-
EPS (Basic)	-1.48	-1.48	-2.24	-2.61	-10.61
EPS (Diluted)	-1.48	-1.48	-2.24	-2.61	-10.61
Free Cash Flow	-44.91	-46.21	-29.88	-19.7	-26.72
Free Cash Flow Per Share	-1.25	-1.39	-1.99	-2.23	-13.27
Gross Margin	92.06%	93.26%	94.03%	-	97.46%
Operating Margin	-2454.15%	-1866.16%	-924.34%	-	-328.81%
Profit Margin	-2330.46%	-1779.71%	-951.26%	-	-374.45%
Free Cash Flow Margin	-2026.67%	-1674.09%	-845.74%	-	-468.56%
EBITDA	-49.94	-48.2	-32.82	-21.91	-21.55
EBITDA Margin	-2253.47%	-1746.41%	-928.81%	-	-377.85%
Depreciation & Amortization	0.82	0.92	0.79	0.18	0.14
EBIT	-50.76	-49.12	-33.61	-22.09	-21.69
EBIT Margin	-2290.52%	-1779.71%	-951.26%	-	-380.26%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).